Statistical Considerations for an Adaptive Design for a Serious Rare Disease

Therapeutic Innovation & Regulatory Science
Kaushik PatraGary Cutter

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is a rare, disabling autoimmune disorder of the central nervous system. Clinical trials in NMOSD present unique design and statistical challenges to adequately determine treatment effect and to minimize risk. The N-MOmentum trial (NCT02200770) is evaluating the efficacy and safety of MEDI-551, an anti-CD 19 B-cell depleting monoclonal antibody, in patients with NMOSD and employs a number of unique design features. Patients are randomized (3:1) to receive MEDI-551 or placebo for up to 197 days. NMOSD attacks are evaluated by the investigator and confirmed by an independent adjudication committee. The primary endpoint is time to first relapse as determined by adjudication committee. Sample size re-estimation and futility analyses are planned interim analyses. Novel multiplicity adjustment methods are developed to control the study-wise type I error. Methods for assessing inter- and intrarater reliability are proposed. The N-MOmentum study minimizes exposure to placebo for individual patients. The application of several statistical methods in the N-MOmentum trial is novel in NMOSD and aims to achieve a balance between minimizing risk and maintaining scientific integrity.

References

Jul 18, 2002·Epidemiologic Reviews·Janet Wittes
Jul 19, 2005·Journal of Biopharmaceutical Statistics·Gang LiYining Wang
Jul 9, 2008·Journal of Biopharmaceutical Statistics·Tony VangeneugdenHelena Geys
Sep 10, 2008·Archives of Neurology·Anu JacobBruce A C Cree
Dec 4, 2008·Statistics in Medicine·Frank BretzMartin Posch
May 31, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Gurdesh S BediWilliam A Sheremata
Oct 4, 2012·Computer Methods and Programs in Biomedicine·Josep L CarrascoVernon M Chinchilli
Jan 24, 2014·International Journal of MS Care·Ruth Ann Marrie, Caroline Gryba
Jul 2, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hajime UnoLee-Jen Wei
Feb 18, 2015·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R Bernard-ValnetR Marignier
Apr 30, 2015·Multiple Sclerosis : Clinical and Laboratory Research·L PanditUNKNOWN GJCF International Clinical Consortium & Biorepository for Neuromyelitis Optica
Nov 23, 2015·Multiple Sclerosis and Related Disorders·Bruce A C Cree
Sep 1, 2015·Therapeutic Innovation & Regulatory Science·Frank J SasinowskiJames E Valentine

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02200770

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.